Real People. Real Data. Real Results.

Accelerate Your Pipeline. Realize Health Equity.

Acclinate is the only mission-critical platform that fuses always-on community trust (Touch) with patented AI/ML technology (Tech). We deliver predictive, representative data that reduces operational risk, accelerates timelines and mobilizes 1 million people to take action for better health.

Request a Demo

Partner of choice for the world’s top pharmaceutical organizations

Our Impact at a Glance

Your Diversity Enrollment
Problem, Solved.

Through culturally relevant engagement and a proven three-stage model, we move individuals from awareness to enrollment — helping partners meet engagement goals while strengthening long-term brand equity.

180K+

Members

Authentic, always-on NOWINCLUDED community — growing nationally.

100+

Community Events

In-person connection that fuels trust and real-world behavior change.

50+

Clinical Trials Supported

Across diverse disease areas and complex recruitment environments.

Therapeutic Areas

Consistent engagement and education across high-priority conditions.

31M+

Overall Reach

Multi-channel visibility from culturally relevant content, education, and touchpoints.

Our Platform

Representative Data = Better Science + Smarter Business

Acclinate transforms community trust into predictive, representative enrollment intelligence that eliminates guesswork and reduces operational risk.

INPUT

Proprietary Community Data

180K+ members generating structured, authenticated signals across channels and therapeutic areas.

ENGINE

e-DICT (Patented AI/ML Engine)

Transforms real-world trust signals into:

Participation Probability Index (PPI)

Study + site-level insights

Demographic forecasting

Real-time dashboards

Predictive scoring

OUTPUT

Predictive Enrollment Intelligence

Delivering inclusive, data-driven visibility into:

Reach + alignment

Site readiness + retention risk

Behavioral readiness

Engagement trends

Participation likelihood

Our Products

A Trust-First Approach to
Inclusive Enrollment

Acclinate pairs culturally grounded engagement with real-time behavioral data to identify who is ready to act—and why. Because enrollment only happens after trust is earned. Powered by our Affective Trust Framework, our three-stage model moves individuals from awareness to action—improving enrollment feasibility and delivering more representative data.

Access

Reach underrepresented populations through culturally aligned content and trusted community channels.

Explore NOWINCLUDED

Engage

Turn awareness into real interest through events, storytelling, and personalized experiences that signal true trial readiness.

Explore NOWINCLUDED

Mobilize

Convert trust into action as high-intent individuals complete pre-screeners, connect with sites, and move toward enrollment.

Explore e-DICT

Access

Reach underrepresented populations through culturally aligned content and trusted community channels.

Explore NOWINCLUDED

Engage

Turn awareness into real interest through events, storytelling, and personalized experiences that signal true trial readiness.

Explore NOWINCLUDED

Mobilize

Convert trust into action as high-intent individuals complete pre-screeners, connect with sites, and move toward enrollment.

Explore e-DICT

Why It Works

The Affective Trust Framework

Every touchpoint reduces friction, addresses unspoken fears, and respects lived experience—creating the psychological safety required for enrollment in historically underrepresented communities.

Barrier Insight

Real-Time Sentiment

Health Knowledge

Participation Intent

Built for Pharma’s New Reality

Trust is the new enrollment driver. Representation is a requirement. Behavioral data is the differentiator. We bring all three together. You are navigating rising FDA scrutiny and the shift toward trust-centered engagement. Acclinate delivers the community insights and behavioral data that fuel enrollment and strengthen trial design.

Clinical Operations

Strengthen Enrollment Feasibility

Close diversity gaps and accelerate timelines with predictive intelligence and trusted community pipelines across more therapeutic areas.

Commercial/Marketing

Engage Patients With Confidence

As FDA scrutiny reshapes DTC, Acclinate enables compliant, unbranded disease education and omnichannel engagement built on cultural trust and real behavioral signals.

Patient Insights

Design Studies Around Lived Experience

Amplify patient and caregiver voices, gather real-world sentiment, and turn community insights into more inclusive protocol design and post-market understanding.

Community Partners

Build Trusted Pathways Together

Partner with local organizations to expand reach, deepen trust, and surface insights that strengthen clinical and commercial strategies.

Customer Success Stories

Trusted Voices, Proven Impact

IBD

Improving Inflammatory Bowel Disease Outcomes

Though irritable bowel disease (IBD) is classically associated with White patient populations, these conditions have been on the rise in communities of color. In fact, rates of Crohn’s disease and ulcerative colitis among those who identify as Black and Hispanic increased 134% from 1970 to 2010.1

Read Case Study

47.9K+

members engaged through our omnichannel approach

660+

in-depth surveys collected from community members

150+

personal stories filmed through NOWINCLUDED